| ¿µ¹® | whole blood | ÇÑ±Û | ÀüÇ÷, ¿ÂÇ÷¾× |
|---|---|---|---|
| ¼³¸í | Ç÷¾×ÀÇ ¸ðµç ¼ººÐÀÌ Çϳªµµ Á¦°ÅµÇÁö ¾ÊÀº ¿ÂÀüÇÑ Ç÷¾×. ÀüÇ÷Àº ¾ö°ÝÇÑ ¹«±ÕÁ¶°ÇÇÏ¿¡¼, ¼±º°ÇÑ °øÇ÷ÀڷκÎÅÍ Ã¤ÃëÇÑ °ÍÀ̸ç, ±¸¿¬»ê ÀÌ¿ÂÀ̳ª ÇìÆÄ¸° °°Àº Ç×ÀÀ°øÁ¦·Î ÀÀ°í¸¦ ¹æÁöÇÏ¿© Ç÷¾×º¸Ãæ ¸ñÀûÀ¸·Î »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | blood collection | ÇÑ±Û | äÇ÷ |
|---|---|---|---|
| ¼³¸í | 1. ¸ð¼¼°üÇ÷ : Ç÷±¸¼ö-Ç÷¼ÒÆÇ¼ö °è»ê, Ç÷»ö¼Ò·®, Ç÷±¸¿ëÀûÃøÁ¤, µµ¸»Ç¥º»Á¦ÀÛ µîÀ» ÇÒ¶§ »ç¿ëµÈ´Ù. ±ÓºÒ ¶Ç´Â ¼Õ°¡¶ô³¡¹Ù´Ú¸éÀ» ÃæºÐÈ÷ ¸¶ÂûÇÑ ´ÙÀ½, ¾ËÄڿ÷Π¼Òµ¶-°ÇÁ¶½ÃÄѼ, ÀÛÀº Ä® ¶Ç´Â Á¾µÎħ ȤÀº 1mmÀÇ ÁÖ»çħÀ¸·Î 2~3mmÀÇ ±íÀ̱îÁö Â´Ù. ¸ÇóÀ½ Çǹæ¿ïÀº ´Û¾Æ³½ ÈÄ ´ÙÀ½ Ç͹æ¿ïÀ» °Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù. 2. Á¤¸ÆÇ÷ : ´ë·®ÀÇ Ç÷¾×À» ¿äÇÏ´Â °æ¿ì¿¡ »ç¿ëÇÑ´Ù. º¸Åë (ÆÈ²ÞÄ¡Á¤ÁßÇǺÎ)ÁÖÁ¤ÁßÇÇÁ¤¸ÆÀ» Â¸ç, ¿µÀ¯¾ÆÀÇ °æ¿ì¿¡´Â ¿Ü°æÁ¤¸ÆÀ» ¼±ÅÃÇϱ⵵ ÇÑ´Ù. ÁöÇ÷¿ë °í¹«ÁÙ·Î »ó´ÜÀ» ÃÖÀúÇ÷¾Ð¿¡ »ó´çÇÏ´Â Á¤µµ·Î ¹°í, ÁÖ¸ÔÀ» ²À Áã°Ô ÇÏ¿© Á¤¸ÆÀ» ³ëÃâ½ÃŲ ÈÄ ¸ê±Õ°ÇÁ¶ÁÖ»ç±â¸¦ Ç÷°ü³»¿¡ »ðÀÔÇÑ´Ù. °ð ¹Ù·Î °í¹«ÁÙ°ú ÁÖ¸ÔÀ» Ç®°í äÇ÷À» ÇÑ ´ÙÀ½ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö´Â´Ù. 2ºÐÀÌ»óÀÇ Á¤¸Æ ¿ïÇ÷Àº Ç÷¾×¼º»ó¿¡ º¯È¸¦ °¡Á®¿Â´Ù. 2. µ¿¸ÆÇ÷ : À§ÆÈµ¿¸Æ ¶Ç´Â ³Ò´Ù¸® µ¿¸ÆÀ» »ç¿ëÇÏ¿© õÀںθ¦ ¼Òµ¶ÇÑ ´ÙÀ½, ÇÁ·ÎÄ«ÀÎ ±¹¼Ò¸¶Ã븦 ÇÑ´Ù. äÇ÷ÀÚ ¿Þ¼ÕÀÇ °¡¿îµ¥¼Õ°¡¶ô°ú µÑ°¼Õ°¡¶ôÀ¸·Î µ¿¸ÆÀ» °íÁ¤Çϰí, ÁÖ»çħÀ» µ¿¸Æ¿¡ 45~65¡ÉÀÇ °¢µµ·Î Âñ·¯ ³Ö¾î äÇ÷ ÈÄ ¸öÂʵ¿¸ÆÀ» ¾öÁö¼Õ°¡¶ôÀ¸·Î ¾Ð¹ÚÇÏ¸é¼ ÁÖ»çħÀ» »©°í, ±× µÚ 5ºÐ°£Âë Â ºÎÀ§¸¦ ¾Ð¹ÚÇÑ´Ù. |
||
| ¿µ¹® | blood-brain barrier(BBB) | ÇÑ±Û | Ç÷³úÀ庮 |
|---|---|---|---|
| ¼³¸í | ³ú¿Í ô¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í ô¼ö¿¡ Á¸ÀçÇÏ´Â ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù. |
||
| ¿µ¹® | blood sugar | ÇÑ±Û | Ç÷´ç |
|---|---|---|---|
| ¼³¸í | Ç÷¾× ¼Ó¿¡ Æ÷ÇԵǾî ÀÖ´Â Æ÷µµ´ç. ³ú¿Í ÀûÇ÷±¸ÀÇ ¿¡³ÊÁö¿øÀÌ µÇ°í, ±× ¾çÀº ¿îµ¿, ½Ä»ç µûÀ§¿¡ ÀÇÇÏ¿© ´Þ¶óÁø´Ù. °Ç°ÀÎÀÇ ¾ÆÄ§ °øº¹½Ã Ç÷Áß Æ÷µµ´ç ³óµµ´Â 60~100mg/dL ÀÌÁö¸¸ ±âŸÀÇ ´çÁú Áï °ú´ç, °¥¶ôÅ佺, 5ź´çÀº ¹Ì·®À̸ç ÀϹÝÀûÀ¸·Î Ç÷´çÀ̶ó Çϸé Ç÷Á߯÷µµ´çÀ» ÀǹÌÇÑ´Ù. Ç÷´çÀº »ýüÀÇ ¿¡³ÊÁö¿øÀ¸·Î¼ °¡Àå Áß¿äÇÑ ¹°ÁúÀÌ´Ù. ±× ³óµµ´Â Àå°üÀ¸·ÎºÎÅÍÀÇ Èí¼ö, °£¿¡ ÀÖ¾î¼ÀÇ ´ç½Å»ý°ú ±Û¸®ÄÚ°ÕÀÌ ÇÕ¼º-ºÐÇØ, ¸»ÃÊÁ¶Á÷ÀÇ ´çÀÌ¿ë ÄáÆÏÀ¸·ÎºÎÅÍÀÇ ¹è¼³ µî ¿©·¯ ÀÎÀÚ¿¡ ÀÇÇØ Á¿ìµÇ¸ç ±× Á¶Àý¿¡´Â ÀÚÀ²½Å°æ°ú °¢Á¾ È£¸£¸óÀÌ ¹ÐÁ¢ÇÏ°Ô °ü°èÇÑ´Ù. ƯÈ÷ Ç÷´çÀúÇÏÀÛ¿ë¿¡´Â Àν¶¸°ÀÌ, ±×¸®°í Ç÷´ç»ó½ÂÀÛ¿ë¿¡´Â ¿¡Çdz×ÇÁ¸°, ±Û·çÄ«°ï, ¼ºÀåÈ£¸£¸ó, ºÎ½Å°ÑÁúÈ£¸£¸ó, ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, °©»ó»ù È£¸£¸óÀÌ °ü°è°¡ ÀÖÀ¸¸ç ±×°ÍµéÀÇ ´ëÇ× ¹× ÇùÁ¶ÀÛ¿ë¿¡ ÀÇÇØ Ç÷´çÄ¡°¡ Á¶ÀýµÈ´Ù. |
||
| HBF | hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala... |
|---|---|
| CCL | carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca... |
| CL | capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ... |
| SAL | sensorineural activity level; sterility assurance level; suction-assisted lipectomy |
| SDL | serum digoxin level; speech discrimination level |
| serum iron level | A test that measures the amount of iron (Fe ++) in the blood. The test is performed when iron deficiency is suspected. Normal serum iron is 60 to 170 mcg/dl. Increased levels may be seen in the following: haemochromatosis, haemolysis, haemolytic anaemia, hepatitis, liver necrosis, haemosiderosis, iron poisoning and lead toxicity. Lower than normal levels are seen in chronic GI blood loss, iron deficiency anaemia, insufficient dietary iron, malabsorption, chronic heavy menstrual bleeding, nephrosis and late pregnancy. (27 Sep 1997) |
|---|---|
| sound pressure level | A measure of sound energy relative to 0.0002 dynes/cm2, expressed in decibels. (05 Mar 2000) |
| substrate-level phosphorylation | Synthesis of high-energy phosphate bonds through reaction of inorganic phosphate with an activated (usually) organic substrate. (09 Oct 1997) |
| no-observed-adverse-effect level | The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed) (12 Dec 1998) |
| organic level | The amount of organic matter prescribed to be left after logging. (05 Dec 1998) |
| trophic level | <biology> Stage in a food chain or web leading from primary producers (lowest trophic level) through herbivores to primary and secondary carnivores (consumers- highest level). (09 Oct 1997) |
| lactate level | A test that measures the amount of lactic acid in the blood. Lactic acid is an intermediate product of carbohydrate metabolism and is derived mainly from muscle cells and red blood cells. Exercise will normally raise lactic acid levels. Conditions of oxygen deprivation (for example shock, heart failure, lung disease) will trigger anaerobic metabolism within muscle tissue resulting in lactic acid build up in the tissues. Normal lactic acid levels are 4.5 to 19.8 mg/dl. (27 Sep 1997) |
| lactic acid level | <investigation> A test that measures the amount of lactic acid in the blood. (25 Jun 1999) |
| free calcium level | <biochemistry> The ionised calcium represents the calcium (Ca++) that is the metabolically active calcium. Normal values for ionised calcium in the bloodstream should be 4.4 to 5.3 mg/dl for adults and 4.4 to 6.0 mg/dl for children. Elevations may be seen in hyperparathyroidism, metastatic bone tumour, milk-alkali syndrome, multiple myeloma, Paget's disease, sarcoidosis, PTH-secreting tumours (paraneoplastic syndrome) and vitamin D intoxication. Lower than normal values may be seen in hypoparathyroidism, malabsorption, osteomalacia, pancreatitis, renal failure, rickets and vitamin D deficiency. (27 Sep 1997) |
| level of aspiration | <psychology> The degree or quality of performance (exhibited in a testing situation) which an individual desires to attain or feels he can achieve. (05 Mar 2000) |
| abdominal wall fat pad biopsy | <investigation, procedure, surgery> The removal of a small specimen of the abdominal wall fat pad for microscopic examination. Often used in the diagnosis of amyloidosis. Performed with a local anaesthetic. (25 Jun 1999) |
| Bichat's fat-pad | An encapsuled mass of fat in the cheek on the outer side of the buccinator muscle, especially marked in the infant; supposed to strengthen and support the cheek during the act of sucking. Synonym: corpus adiposum buccae, Bichat's fat-pad, Bichat's protuberance, fat body of cheek, sucking cushion, sucking pad, suctorial pad. (05 Mar 2000) |
| brown fat | A thermogenic type of adipose tissue containing a dark pigment, and arising during embryonic life in certain specific areas in many mammals, including man. It is prominent in the newborn of all species in which it occurs and remains a distinct and conspicuous tissue in the adults of certain species, especially those that hibernate. It is also called brown adipose tissue. (12 Dec 1998) |
| brown fat cell | <pathology> Brown fat is specialised for heat production and the adipocytes have many mitochondria in which an inner membrane protein can act as an uncoupler of oxidative phosphorylation allowing rapid thermogenesis. (18 Nov 1997) |
| buccal fat-pad | An encapsuled mass of fat in the cheek on the outer side of the buccinator muscle, especially marked in the infant; supposed to strengthen and support the cheek during the act of sucking. Synonym: corpus adiposum buccae, Bichat's fat-pad, Bichat's protuberance, fat body of cheek, sucking cushion, sucking pad, suctorial pad. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|